Study identifies potential drug target for prostate cancer
Researchers have discovered a non-coding RNA which could be used as a biomarker and in new therapies for prostate cancer.
List view / Grid view
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
Researchers have discovered a non-coding RNA which could be used as a biomarker and in new therapies for prostate cancer.
Researchers have found that fat cells transfer cytokines to melanoma cells, which transforms them into aggressive tumours, indicating a drug target for the condition.
A new study has found a novel way to target an enzyme involved in cancer growth, which could inform therapeutics for the condition.
Researchers have identified a protein that plays a role in promoting blood cancer and have successfully used a novel compound to inhibit it, reducing tumour growth.
A new study has shown that proteins derived from the oncogene, KRAS, can transfer between colon cancer cells.
A protein has been discovered as key for effective chemotherapy, meaning improved treatments for chemotherapy resistance can be developed.
A study has identified a gene key in the spread of cancer, which could point to improving treatments for the condition, say the researchers.
Researchers have discovered that inhibiting the ID1 protein slows the growth of glioblastoma tumours and reduces resistance to chemotherapy.
From the world’s flagship neutron science facility, Institut Laue-Langevin (ILL), Matthew Blakeley shares insights into how they are harnessing the power of neutrons to aid their search for new cancer treatments.
New research has found a strain of the common cold that can attack cancer cells in the bladder resulting in cell death with no side effects.
Researchers have discovered a pathway which when blocked can cause cancer cell death, pointing to new therapies.
A new study has discovered the role of a protein in controlling the development of skin pigment genes.
Researchers have discovered that lung cancer cells metastasise using antioxidants, informing potential future therapies.
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
Researchers have found two biomarkers which play a significant role in the invasion of tumours by T-cells.